Lipid metabolism as a driver of therapy resistance in triple negative breast cancer
5 Articles
5 Articles
Lipid metabolism as a driver of therapy resistance in triple negative breast cancer
Lipid metabolism has emerged as a central player in the progression and therapy resistance of breast cancer, particularly the aggressive subtype known as triple-negative breast cancer (TNBC).
The Role of Lipid Metabolism in Breast Cancer Progression and Treatment Resistance
SHANNON, CLARE, IRELAND, April 20, 2025 /EINPresswire.com/ -- Lipid metabolism has emerged as a central player in the progression and therapy resistance of breast cancer, particularly the aggressive subtype known as triple-negative breast cancer (TNBC). This review article highlights how disruptions in lipid regulation can significantly influence the behavior of breast cancer cells, impacting their growth, metastasis, and response to treatment. …
92 Near-Infrared Fluorescence Imaging With Indocyanine Green vs Isosulfan Blue for Sentinel Lymph Node Mapping: Comparative Cost Analysis in Early-Stage Breast Cancer
Home to the journal Oncology, Cancer Network provides research and opinion on the screening, early detection, diagnosis, treatment, and prevention of cancers.
Delaware Breast Cancer Coalition to host 27th annual Brease Cancer Update event
The Delaware Breast Cancer Coalition looks to inform about the community about the risks of Triple Negative Breast Cancer in its free 27th annual Breast Cancer Update, 'Breast Cancer: The State We're In'.
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage